- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02930031
Redox Status and Immune Function
Evidence of a Redox-dependent Regulation of Immune Responses to Exercise-Induced Inflammation
Study Overview
Status
Intervention / Treatment
Detailed Description
The major thiol-disulfide couple of GSH and oxidized glutathione (GSSG) is a crucial regulator of the main transcriptional pathways regulating aseptic inflammation and recovery of skeletal muscle following aseptic injury. Antioxidant supplementation may hamper exercise-induced inflammatory responses.
The objective was to examine how thiol-based antioxidant supplementation affects immune mobilization following exercise-induced skeletal muscle microtrauma. In a two-trial, double-blind, crossover, repeated measures design, 10 young men received either placebo or NAC (20 mg/kg/day) immediately after a muscle-damaging exercise protocol (300 eccentric contractions) and for eight consecutive days. Blood sampling and performance assessment were performed pre-exercise, 2h post-exercise and daily for 8 consecutive days.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Athens, Greece, 11527
- University of Athens, Medical School, Department of Clinical Therapeutics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Recreationally trained (VO2max > 45 ml/kg/min)
- Engaged in regular exercise for ≥3 times/week for > 12 months
- non-smokers
- Abstain from exercise during the course of the two trials
- No consumption of performance-enhancing substances, antioxidants, caffeine, alcohol and/or medications during the study.
Exclusion Criteria:
- NAC intolerance
- Recent musculoskeletal injuries of the lower limbs
- Febrile illness
- History of muscle lesion.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: n-acetylcysteine
orally in three daily dosages, at 20 mg/kg/day, daily for eight days after exercise
|
20 mg//kg/day, orally, daily for eight days following exercise
Other Names:
|
Active Comparator: Placebo
orally in three daily dosages, content: 500 mL drink that contained water (375 mL), sugar-free cordial (125 ml), and 2 g of low-calorie glucose/dextrose powder
|
500 mL orally, daily for eight days following exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in protein carbonyls in red blood cells
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Concentration of protein carbonyls
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in thiobarbituric acid reactive substances in red blood cells
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Thiobarbituric acid reactive substances concentration in red blood cells
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in total antioxidant capacity in serum
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
|
Changes in reduced glutathione in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Concentration of reduced glutathione in red blood cells
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in oxidized glutathione in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Concentration of oxidized glutathione in red blood cells
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in catalase activity in red blood cells
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
|
Changes in creatine kinase activity in serum
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
|
Changes in high sensitivity C-reactive protein in serum
Time Frame: Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise
|
Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise
|
|
Changes in white blood cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
|
Changes in adhesion molecule concentration in blood
Time Frame: Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise
|
Measurement of soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble intercellular cell adhesion molecule-1 (sICAM-1) concentrations in plasma
|
Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise
|
Changes in cytokine concentration in serum
Time Frame: Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise, 8 days post-exercise
|
Measurement of interleukin-1β (IL-1β) and interleukin-6 (IL-6)
|
Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise, 8 days post-exercise
|
Changes in neutrophil count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of neutrophil count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in lymphocyte count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of lymphocyte count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in monocyte count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of monocyte count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in basophil count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of baseophil count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in eosinophil count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of eosinophil count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in T-helper cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of T-helper cell count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in T cytotoxic cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of T cytotoxic cell count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in natural killer-T (NK-T) cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of NK-T cell count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in 62L macrophage count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of 62L macrophage count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in B lympho cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of B lympho cell count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in natural killer (NK) cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of natural killer cell count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in macrophage count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of macrophage count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in HLA+/Macr+ macrophage count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of HLA+/Macr+ count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in 11B+ macrophage count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Cytofluorometric analysis of 11B+ macrophage count in blood
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximal aerobic capacity
Time Frame: One day before exercise
|
Assessment of maximal oxygen consumption
|
One day before exercise
|
Changes in muscle performance
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Assessment of maximal knee extensor eccentric peak torque on an isokinetic dynamometer at 60o/s.
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Changes in delayed onset of muscle soreness
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Assessment of the delayed onset of muscle soreness by palpation of the vastus lateralis and rectus femoris following a squat motion
|
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
|
Body composition
Time Frame: One day before exercise
|
Measurement of body composition by Dual Emission X-ray Absorptiometry (DXA)
|
One day before exercise
|
Changes in dietary intake profile
Time Frame: One day before exercise and daily for 8 consecutive days post-exercise
|
Assessment of dietary intake with emphasis on antioxidant element intake
|
One day before exercise and daily for 8 consecutive days post-exercise
|
Collaborators and Investigators
Investigators
- Study Director: Asimina Mitrakou, Associate Prof., Department of Diabetes and Metabolism Unit of the Department of Clinical Therapeutics, National and Kapodistrian University of Athens
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NACEXERCISE2016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skeletal Muscle Damage
-
University of ThessalyCompletedAthletic Performance | Muscle Damage | Skeletal Muscle DamageGreece
-
University of ThessalyCompleted
-
Democritus University of ThraceCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Intgracellular Signaling in Skeletal Muscle | Inflammatory StatusGreece
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Intracellular Signaling in Skeletal Muscle | Proteasome ActivationGreece
-
University of ThessalyRecruiting
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Antioxidant StatusGreece
-
University of ThessalyCompletedMuscle Inflammation | Skeletal Muscle Damage | Soccer Performance | Muscle RecoveryGreece
-
AdventHealth Translational Research InstituteActive, not recruiting
-
University of ThessalyCompletedPerformance | Skeletal Muscle Damage | Exercise-induced Aseptic InflammationGreece
Clinical Trials on n-acetylcysteine
-
Medical University of South CarolinaCompleted
-
Institut d'Anesthesiologie des Alpes MaritimesCompleted
-
Rajavithi HospitalCompletedChemotherapy-induced Peripheral NeuropathyThailand
-
University of Sao Paulo General HospitalActive, not recruiting
-
Indiana UniversityBioAdvantex PharmaCompletedHIV | Endothelial Dysfunction | Oxidative StressUnited States
-
Assaf-Harofeh Medical CenterUnknownChronic Kidney Diseases | General AnesthesiaIsrael
-
Assistance Publique - Hôpitaux de ParisTerminatedSelenoprotein N-related MyopathyFrance
-
VA Office of Research and DevelopmentNational Center for Complementary and Integrative Health (NCCIH)CompletedDiabetic Nephropathy | Proteinuria | Oxidative StressUnited States
-
University of ChicagoNational Institute on Drug Abuse (NIDA); University of MinnesotaCompletedTobacco Use Disorder | GamblingUnited States
-
Universidade Estadual de LondrinaUnknownInflammation | Tobacco Smoking | Oxidative StressBrazil